Skip to main content

SELECTing the right patients: upadacitinib in GCA

Dr. Brian Jaros reports on abstract 1695, presented at the 2024 ACR Convergence meeting in Washington, DC.

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.